ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,209Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 2604

$718K Total Retail Price of All Prescriptions

Rank: 71 out of 2604

404 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 3,628 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 469 113 S3 1 1
SIMVASTATIN 346 176 2 2
LISINOPRIL 320 114 3 3
METFORMIN HCL 311 174 4 7
TRAMADOL HCL 250 66 5 15
LEVOTHYROXINE SODIUM 209 129 6 4
FUROSEMIDE 189 78 7 8
OMEPRAZOLE 180 73 8 5
AMLODIPINE BESYLATE 172 89 9 6
SPIRIVA 133 50 10 45
ZOLPIDEM TARTRATE 130 40 11 21
FENOFIBRATE 118 21 12 69
SERTRALINE HCL 117 24 13 23
PROAIR HFA 111 36 14 27
ATENOLOL 106 47 15 11
VESICARE 106 59 15 187
CARVEDILOL 99 63 17 26
LYRICA 96 13 18 79
HYDROCHLOROTHIAZIDE 95 48 19 10
LOSARTAN POTASSIUM 93 90 20 20
CYCLOBENZAPRINE HCL 91 0 R 21 43
NEXIUM 91 48 21 53
TOPIRAMATE 90 17 23 143
ADVAIR DISKUS 87 31 24 41
LOVASTATIN 86 58 25 24
VENTOLIN HFA 85 20 26 63
IBUPROFEN 83 12 27 32
ZETIA 73 23 28 94
POLYETHYLENE GLYCOL 3350 72 20 29 42
RANITIDINE HCL 69 11 30 25
ACTOS 68 24 31 116
ATORVASTATIN CALCIUM 68 34 31 19
FLUOXETINE HCL 67 25 33 49
PEN NEEDLE 66 24 34 145
GABAPENTIN 61 19 35 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 50 36 22
MORPHINE SULFATE ER 56 13 S2 37 58
NAPROXEN 54 30 38 76
DEXILANT 54 12 38 323
LANTUS SOLOSTAR 51 0 40 84
GLIPIZIDE 51 21 40 51
ACYCLOVIR 51 0 40 382
LANSOPRAZOLE 50 20 43 137
ENALAPRIL MALEATE 50 28 43 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.